Optinose


























Piper Jaffray has just announced that they have targeted Optinose at $29 per share... All I can say is those folks are sniffing something, and it's definitely NOT coming out of a puffer. If we see that price, I will eat my boots!!!
 








































Sneaky Pete will announce another bombshell like he did when he said he met with CEO of FC and there were 17 K RX not adjudicated and waiting to be filled. Whatever happened to those scripts and our bonus Sneaky Pete? Why can’t your stellar Market Access team can’t get MC wins in states other than Texas and Florida where everything is out in formulary and then we have to listen to what great jobs these reps are doing. It is a joke.
 
































Peter,

Great job with the books!! Somehow, despite the abysmal sales, we continue to beat earnings every quarter. Creative accounting may help us sell this dog before they all figure out it's all a sham.

Tom
 








Interesting that we sold $4M last quarter after 2 years on the market and the stock has not crashed.

Its getting harder to have a straight face when I say the same thing every time: "our new initiatives will drive massive growth NEXT quarter" .

Scary to think these bankers might collapse the economy again.

Drinks?

Tom
 
















The end zone is a moving target and goals keep getting adjusted, just in time to say it was an incomplete pass. Maybe we need the quarterback back up on stage, to tell us what we are doing wrong?
 
























Sneaky Pete will have another round of “ Fast Start” meetings, but instead of “ Lil Tom,” saying this one is on me ( anyone else so inept would be gone), Dave will say, “ Hey Guys, just start pushing the indication we are not approved for. Who really cares about FDA.
 








Sneaky Pete will have another round of “ Fast Start” meetings, but instead of “ Lil Tom,” saying this one is on me ( anyone else so inept would be gone), Dave will say, “ Hey Guys, just start pushing the indication we are not approved for. Who really cares about FDA.
Fabri is well versed in selling indications without approval. He invented it at JNJ -- to the tune of a $2bb fine